GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Down 63.9% in March

GlucoTrack, Inc. (NASDAQ:GCTK) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 283,900 shares, a drop of 63.9% from the February 28th total of 787,200 shares. Based on an average daily volume of 5,750,000 shares, the short-interest ratio is presently 0.0 days. Approximately 2.8% of the shares of the company are short sold.

GlucoTrack Stock Down 4.6 %

NASDAQ:GCTK opened at $0.24 on Thursday. The company’s 50 day moving average is $0.76 and its 200-day moving average is $16.11. The firm has a market cap of $2.52 million, a price-to-earnings ratio of 0.00 and a beta of -0.29. GlucoTrack has a 12 month low of $0.22 and a 12 month high of $99.00.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in GlucoTrack stock. XTX Topco Ltd purchased a new stake in GlucoTrack, Inc. (NASDAQ:GCTK) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 85,394 shares of the company’s stock, valued at approximately $32,000. XTX Topco Ltd owned about 10.63% of GlucoTrack as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 10.92% of the company’s stock.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.